Scientists at the University of Virginia have identified what appears to be a major missing link in the process that destroys nerve cells in Alzheimer?s disease, an incurable disease that slowly destroys memory and cognitive abilities.
A decades-old cancer mystery has been solved by researchers at Cold Spring Harbor Laboratory (CSHL). “We not only found a critical tumor suppressor gene, but have revealed a master switch for a tumor suppressive network that means more targeted and effective cancer therapy in the future,” said CSHL Associate Professor Alea Mills, Ph.D. The study, headed by Mills, was published in the February issue of Cell.
There is an increased risk of fetal heart problems when mothers carry particular antibodies associated with rheumatic diseases, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference February 9 in San Francisco.
Antibiotics to treat respiratory infections can increase resistance to the drugs, Belgian scientists reported the findings in The Lancet medical journal.
Folate may protect cognition in seniors, but only with adequate levels of vitamin B12. In an epidemiological study, low B-vitamin status was associated with anemia and cognitive impairment. Low vitamin B12 status was especially linked to these conditions if seniors also had high folate in the blood.
In response to a glut of confusing and sometimes incorrect information about public and private banking of umbilical cord blood, the American Academy of Pediatrics (AAP) has issued new recommendations that seek to clarify the options available to parents.
A research team led by Research Director Dr. Will Garrett-Petts of Thompson Rivers University is now ready to share preliminary descriptive results from a five-community Arts and Quality of Life Survey.
Researchers at the Stanford University School of Medicine and the Northern California Cancer Center have taken the first steps toward analyzing why people who never smoked get lung cancer.
Researchers at the University of Pennsylvania School of Medicine are the first to show that a mouse protein, whose human equivalent is related to defense against HIV-1, inhibits the infection and spread of a mouse tumor virus.
Abnormal proteins in amniotic fluid that signal a higher risk of delivering prematurely are being detected with increasing accuracy by Yale School of Medicine researchers who presented their work in two abstracts at the Society for Maternal-Fetal Medicine Conference February 8 in San Francisco.